DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 4 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,183,170 | -29.5% | 105,825 | +0.9% | 0.00% | 0.0% |
Q2 2023 | $3,095,364 | +37.6% | 104,892 | +7.5% | 0.00% | 0.0% |
Q1 2023 | $2,249,120 | -14.9% | 97,618 | +2.7% | 0.00% | 0.0% |
Q4 2022 | $2,642,365 | +0.1% | 95,015 | +10.5% | 0.00% | 0.0% |
Q3 2022 | $2,640,000 | +3.7% | 86,017 | -0.6% | 0.00% | 0.0% |
Q2 2022 | $2,546,000 | -0.4% | 86,503 | +8.9% | 0.00% | 0.0% |
Q1 2022 | $2,555,000 | -27.5% | 79,426 | +0.6% | 0.00% | 0.0% |
Q4 2021 | $3,523,000 | -9.9% | 78,971 | +1.9% | 0.00% | 0.0% |
Q3 2021 | $3,911,000 | -19.9% | 77,528 | +24.6% | 0.00% | -50.0% |
Q2 2021 | $4,883,000 | +96.3% | 62,244 | +42.9% | 0.00% | +100.0% |
Q1 2021 | $2,487,000 | -33.9% | 43,550 | -3.0% | 0.00% | 0.0% |
Q4 2020 | $3,761,000 | +165.2% | 44,897 | +13.4% | 0.00% | 0.0% |
Q3 2020 | $1,418,000 | +68.8% | 39,586 | +13.9% | 0.00% | – |
Q2 2020 | $840,000 | +82.6% | 34,754 | +32.3% | 0.00% | – |
Q1 2020 | $460,000 | -4.6% | 26,278 | -5.0% | 0.00% | – |
Q4 2019 | $482,000 | +22.0% | 27,659 | +7.2% | 0.00% | – |
Q3 2019 | $395,000 | -26.3% | 25,798 | 0.0% | 0.00% | – |
Q2 2019 | $536,000 | -8.7% | 25,798 | +1.9% | 0.00% | – |
Q1 2019 | $587,000 | +227.9% | 25,308 | +193.0% | 0.00% | – |
Q4 2018 | $179,000 | +10.5% | 8,638 | +16.3% | 0.00% | – |
Q3 2018 | $162,000 | -23.9% | 7,426 | -46.9% | 0.00% | – |
Q2 2018 | $213,000 | -79.1% | 13,980 | -73.0% | 0.00% | -100.0% |
Q1 2018 | $1,018,000 | +101700.0% | 51,736 | +93965.5% | 0.00% | – |
Q4 2017 | $1,000 | – | 55 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
Artal Group S.A. | 802,899 | $16,564 | 0.71% |